Advertisements

Zacin 0.025%

Quick links to important sections

Zacin 0.025%

Advertisements
Advertisements

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Zacin 0.025%

Property Description
Active ingredient Capsaicin (0.025% w/w)
Form Topical Cream
Pharmacological class Topical Analgesic; TRPV1 Agonist
General use Symptomatic relief of persistent peripheral pain
Origin Derived natural compound (Alkaloid)

What Type of Medicine is Zacin 0.025%?

Zacin 0.025% is a specialized topical analgesic medicinal product, classified as a nonopioid analgesic cream intended for application on the skin to provide symptomatic relief of persistent peripheral pain. This formulation is recognized in medical literature for its unique approach to pain management, which distinguishes it from conventional cooling or heating agents. This medicine is an established single-ingredient formulation of Capsaicin used for targeted, chronic discomfort. It is frequently categorized within the ATC code M02AB01 for topical products addressing joint and muscular pain.


Composition and Core Principles: The Capsaicin Alkaloid

The efficacy of Zacin 0.025% is derived from its single active ingredient, 0.025% Capsaicin, which is a naturally occurring alkaloid. Capsaicin, the core chemical substance, is an alkaloid derived from the Capsicum genus. The 0.025% concentration is a specific strength designed for patient use, delivered in a cream dosage form (w/w) for localized topical delivery. The product's fundamental action involves Capsaicin acting as a TRPV1 Agonist on sensory nerve endings. This established mechanism leads to the functional desensitization of pain-signaling nerves and a reduction in the local availability of Substance P, a key pain neurotransmitter. This confirmed physiological action ensures that the cream works by temporarily modulating the local nerve's ability to communicate pain messages, resulting in the general benefit of providing symptomatic relief by targeting the peripheral signaling pathway.

Regulatory References

  1. NIH DailyMed for Capsaicin 0.025% Cream
Advertisements

What side effects are possible with Zacin 0.025%?

Possible side effects and safety information

The safety profile of Zacin 0.025% cream, a topical analgesic containing capsaicin, is primarily defined by local application site reactions, as documented in official regulatory sources. These reactions are typically categorized by frequency using standard regulatory frameworks.

Officially Classified Adverse Reactions

Adverse reactions are classified according to the system-organ classes involved and their documented frequency:

System-Organ Class Common Reactions (Affecting up to 1 in 10) Uncommon Reactions (Affecting up to 1 in 100)
Skin and Subcutaneous Tissue Disorders Burning sensation, Pain, Erythema (redness), Pruritus (itching), Skin irritation Dry skin, Local hypersensitivity reactions
Other Systems (e.g., Nervous/Respiratory/GI) Headache, Cough, Nausea —

Safety Patterns and Constraints

The most frequent local effects, such as burning and pain at the application site, are officially noted to be most intense at the beginning of treatment (initiation). Regulatory data indicates that the intensity and frequency of these initial reactions tend to decrease with continued and regular use as the skin develops tolerance.

Serious adverse events are rare, but the potential for severe local hypersensitivity reactions is noted. Furthermore, regulatory labels establish strict application constraints: the cream must not be applied to broken skin, open wounds, or near mucous membranes (e.g., eyes, nose, mouth). Use is not established in the pediatric population (under 18 years of age) due to insufficient safety data.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for Zacin 0.025% (Capsaicin topical cream) defines the conditions under which overdose or severe misuse necessitates seeking medical help. This guidance is primarily structured around two scenarios: accidental systemic exposure and severe localized overexposure.

Documented Manifestations and Severe Outcomes

Overdose from the cream may present with severe local manifestations such as blistering, pain, or swelling that develops at the application site. Accidental contact may cause severe irritation of the eyes and other mucous membranes. In cases of accidental ingestion (swallowing) or massive systemic exposure, regulatory documents describe potential severe outcomes that require immediate intervention, including trouble breathing, collapse, seizure, or being unable to be awakened.

Emergency Actions and Medical Help Requirements

If Zacin 0.025% is swallowed, an individual must seek immediate medical help or contact a Poison Control Center right away. For life-threatening manifestations—specifically collapse, seizure, trouble breathing, or inability to be awakened—official guidance mandates that emergency services must be called immediately. If local symptoms like severe persistent burning or blistering occur, the product's use must be stopped, and a physician should be consulted. If the cream contacts the eyes, the affected area should be continually rinsed with cool water while seeking medical assistance. Treatment for systemic overdose is generally described as symptomatic and supportive.

Advertisements

Therapeutic Uses of Zacin 0.025%

Zacin 0.025% Topical Cream is a non-opioid analgesic commonly used to provide localized symptomatic relief for symptoms related to physical discomfort. Its therapeutic applications are generally relevant when supportive symptom management is appropriate for symptoms that interfere with daily functioning.

This cream is applied across domains where additional symptomatic support is needed for pain stemming from nerve damage, such as post-herpetic neuralgia (PHN) and painful diabetic peripheral neuropathy. It is applied in addressing symptom clusters that include sensations like burning, shooting, or stinging discomfort. It is also generally used for conditions presenting with localized discomfort, such as the persistent aching associated with osteoarthritis in specific joints.

“The product is relevant for easing symptoms that become more disruptive during flare-ups, supporting patients during episodes of heightened discomfort.”

The application in these scenarios may assist in easing distress and contributes to easing the overall symptom load, supporting the patient during difficult episodes. Providing supportive relief in these areas may assist with maintaining functional stability and contributes to improved day-to-day comfort during symptomatic periods.


Quick Fact: Relevant for Managing Persistent Peripheral Pain

Regulatory References

  1. NIH DailyMed overview
Advertisements

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Zacin 0.025% — Official Regulatory Information

The eligibility profile for Zacin 0.025% is strictly defined by regulatory warnings and restrictions documented in government-approved prescribing information.


Eligibility Scope

Populations for whom use is allowed (as stated in label):

  • Adults and the Elderly may use the medicine under standard labeled conditions.

Populations for whom use is contraindicated:

  • Patients with a known hypersensitivity or allergy to capsaicin or to chili peppers.
  • Application to broken skin, irritated skin, wounds, or cuts is strictly prohibited.

Age-related eligibility rules:

  • The product is not suitable for use in children according to official regulatory labeling in some jurisdictions.
  • Professional consultation is required for any individual under 18 years of age.

Pregnancy and lactation eligibility status (if explicitly documented):

  • Use during pregnancy or breastfeeding is conditional and requires a healthcare professional to be consulted, as safety data are not established in the labeling.

Eligibility-related restrictions:

  • Individuals with a recent history of specific heart, brain, or blood vessel problems should seek professional guidance before use.

Connection to the overall eligibility profile

Official regulatory documents define who can and cannot use the medicine by strictly excluding patients with known allergies to capsaicin or compromised skin integrity. Use is generally designated for the adult population, with explicit restrictions defining the product as unsuitable for pediatric patients. Use during reproductive periods is conditional upon consultation due to the lack of established safety data.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile for Zacin 0.025% Topical Cream is defined by the minimal systemic absorption of its active ingredient, capsaicin. Official regulatory labeling indicates no known clinically significant pharmacokinetic (PK) interactions with co-administered oral or injectable medicines. Due to the negligible systemic exposure, the product is not documented to interact with metabolic enzymes like Cytochrome P450 (CYP) or drug transporters, and thus does not alter the systemic exposure (AUC or Cmax) of other drugs. Accordingly, no systemic drug combinations are formally listed as contraindicated.


Local and Administrative Restrictions

The primary interaction constraints are local to the application site. Co-administration of other topical medicines, cosmetics, or skin care products on the same area is advised against due to potential local pharmacodynamic effects. The cream has a crucial interaction with heat sources that can intensify the expected sensory effect. For this reason, the use of heating pads, sunlamps, or hot water bottles on the treated area is restricted. Furthermore, regulatory guidance mandates a separation of at least one hour between application and exposure to hot showers, hot baths, or vigorous exercise. There are no known interactions documented with food, drinks, or herbal products.

Advertisements

Mechanism of Action

Targeted Action on the TRPV1 Receptor

The active ingredient is a specific agonist of the Transient Receptor Potential Vanilloid 1 (TRPV1) ion channel, located primarily on the peripheral C-fibers of sensory nerves. This selective interaction initiates the mechanism by forcing the receptor open, leading to a massive influx of calcium ions ( Ca^2+) into the nerve terminal.


The Cascade of Functional Defunctionalization

The sustained, excessive Ca^2+ overload triggers an internal biochemical cascade that results in the long-lasting functional shutdown or desensitization of the TRPV1 receptor. This process renders the entire peripheral nerve terminal refractory and unresponsive to subsequent noxious stimuli, interrupting the afferent signal at its source.


Inhibition of Peripheral Signal Transmission

The resulting physiological effect is the targeted inhibition of afferent signal transduction from the application site to the spinal cord. This mechanism is primarily relevant for processes involving peripheral sensory signaling, resulting in a persistent suppression of the nerve's ability to propagate an electrical signal.

Advertisements

Dosage and Administration Information

How to Use Zacin 0.025%

Zacin 0.025% (Capsaicin) is a specialized topical preparation whose usage is defined by specific guidelines for application, frequency, and duration. The medicine is administered exclusively via the topical route to the affected area of the skin.


Standard Dosing and Frequency

The standard regimen for adults and the elderly involves applying a small amount of the cream—typically described as pea-sized—to the area of discomfort. The cream must be gently rubbed in until it is fully absorbed and no visible residue remains.

  • Frequency: Application is usually 3 or 4 times daily, but must not exceed four applications in a 24-hour period. An interval of at least four hours is required between each use.
  • Duration: The medicine is intended for regular, continuous application. While initial effects may be observed within the first week, optimal benefit typically requires sustained use over four to eight weeks.

Administration Conditions

Proper use is highly dependent on technique and post-application care to ensure safe delivery and function:

  • Hand Washing: Hands must be washed immediately after applying the cream to prevent inadvertent contact with sensitive areas. If the hands themselves are the site of treatment, they should be washed 30 minutes after application.
  • Application Site: The cream must be applied only to unbroken skin. Application near mucous membranes, such as the eyes, is restricted.
  • Covering: Do not apply tight bandages or occlusive dressings over the area where the cream has been used.

Population Rules

Official labeling specifies that the standard regimen applies to adults and the elderly. The product is not suitable for use in children, and medical consultation is mandatory for individuals under 18 years of age to determine suitability.

Advertisements

Recent Clinical Evidence

Zacin 0.025%: Recent Clinical Evidence

Research Conducted for Persistent Pain After Shingles (Post-Herpetic Neuralgia)

Research evaluating the active ingredient, capsaicin 0.025% cream, was explored in patient populations presenting with chronic pain following a shingles infection (Post-Herpetic Neuralgia, or PHN). These studies were designed to compare the measured outcomes of the active cream against an inactive vehicle in adults, including older adults, whose pain had persisted for six months or more. Research protocols identified measured variables related to physical discomfort, primarily including measurements of pain severity. The findings describe patterns observed in the studies over a short duration, typically around 4 to 8 weeks.

Research Conducted on Populations with Localized Osteoarthritis Pain

Studies evaluating the active ingredient, capsaicin 0.025% cream, were conducted in populations presenting with localized Osteoarthritis (OA) pain—such as in the knee or hand—examining symptomatic experiences related to localized pain. Research largely relied on short-term Randomized Controlled Trials (RCTs). Studies monitored patient-reported outcomes describing perceived discomfort and functional measures. Meta-analyses reported patterns of measured outcomes when compared to the vehicle control.

Research Conducted on Populations with Painful Diabetic Peripheral Neuropathy

Research explored the active ingredient, capsaicin 0.025% cream, in patient populations presenting with painful Diabetic Peripheral Neuropathy (PDN), where symptoms may vary in intensity. Data reported patterns related to how symptoms changed in the observed populations during the short treatment periods, which were typically around 8 weeks. However, the findings were mixed, and the evidence quality varies across studies, meaning the certainty remains low for this area of study using this specific strength.

Key Evidence Gaps and Areas of Uncertainty

Studies generally focused on responses over defined, short time intervals. Long-term effects are not fully established regarding the sustained use or durability of any patterns observed in the research. Sample sizes were modest in many trials, which can contribute to the observed variation in study findings. Additionally, data for certain groups remain insufficient, and comparative evidence is lacking to assess this topical therapy against many other available treatments.

Key Studies & References

  1. Capsaicin Topical Cream 0.025% Label and Product Information
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Zacin 0.025% (FAQ)


Q: How quickly does Zacin 0.025% usually start to feel like it's working?

A: The period for experiencing the medicine's measured effect is generally described in studies and consensus reports as requiring 2 to 4 weeks of continuous application. This period of consistent use is necessary for the active ingredient to achieve its effect on the sensory nerve endings. While some users may notice initial changes earlier, the sustained pattern of relief described in research often requires continuous application over this period.


Q: Can Zacin 0.025% be used on the face or sensitive areas?

A: Official warnings state that application near mucous membranes (such as the eyes, mouth, and nostrils) is restricted. Due to the risk of inadvertent exposure to these sensitive areas, some regulatory guidance advises against using the cream on the face or scalp.


Q: Is it normal to feel a slight burning sensation when first applying Zacin 0.025%?

A: A burning, stinging, or tingling sensation at the application site is listed in official documentation as a common occurrence or side effect. Regulatory data indicates that this sensation is typically most intense when treatment is first started. It is officially noted that this effect generally lessens in intensity and frequency with continued, regular use of the product.


Q: What if I accidentally miss an application of Zacin 0.025%?

A: Guidance on managing a missed application states that users should not apply a double amount to catch up. If an application is forgotten, regulatory consensus recommends consulting the original instructions regarding the timing of the next application. Official documents emphasize that applying a double amount is restricted.


Q: Is Zacin 0.025% effective for all types of skin conditions?

A: Regulatory labels define the product's approved use as the symptomatic relief of persistent peripheral pain in adult populations, such as pain related to nerve or localized joint discomfort. It is not generally indicated for other types of skin conditions.


Q: Can Zacin 0.025% make my skin more sensitive to the sun?

A: Official information indicates that the treated skin may have an increased sensitivity to both heat and sunlight. Because of this potential, minimizing prolonged exposure to natural sun and using protective measures are frequently described in usage guidelines.


Q: Does Zacin 0.025% cause skin thinning?

A: The official regulatory lists of common side effects for Zacin 0.025% focus on local application site reactions, such as burning, redness, and irritation. Skin thinning (atrophy) is not listed among the frequently reported adverse effects associated with this medication.


Q: Is Zacin 0.025% safe for use while breastfeeding?

A: Safety has not been established during breastfeeding, and use during this period requires consultation with a healthcare professional. Although systemic absorption is considered low, the product is restricted from application to the nipple or areola area to help prevent infant exposure.


Q: Does the time of day matter when applying Zacin 0.025%?

A: The official product regimen does not specify a particular time of day for application. The official regimen involves 3 to 4 applications daily, with guidance for a minimum interval of four hours between each use to align with the expected pattern of effect.


Q: Can Zacin 0.025% interact with certain herbal supplements?

A: Regulatory information indicates that no known interactions are documented with food, drinks, or herbal products. However, regulatory agencies emphasize the importance of communicating all medicines, supplements, and herbal products being taken to the healthcare provider.


Q: Is Zacin 0.025% safe for use during pregnancy?

A: Safety has not been established in pregnant women, and use during this period necessitates consultation with a healthcare professional. While some regulatory categories suggest limited risk based on non-human data, adequate and well-controlled studies in pregnant women are lacking.


Q: What is the maximum duration of use recommended in official guidelines for Zacin 0.025%?

A: The period for initial assessment is typically described as a trial lasting 4 to 6 weeks to observe individual response patterns. Efficacy is assessed after about 4 to 8 weeks of sustained use; continued use beyond this period is determined based on ongoing assessment.


Q: Does using more Zacin 0.025% make it work faster?

A: Official instructions define the amount to be used as a small, pea-sized amount that is gently rubbed in until absorbed. Using amounts beyond the prescribed measure is not noted to increase speed or efficacy and is associated with a potential for heightened local adverse reactions.


Q: Why do some people experience initial flare-ups when starting Zacin 0.025%?

A: The active ingredient works by interacting with the sensory nerve receptors. This action can initially cause a temporary increase in pain or a localized intense burning sensation. This reaction aligns with the mechanism of action, is described as transient, and officially noted to diminish in intensity with continued regular application.


Q: Can Zacin 0.025% interact with blood pressure medication?

A: Official information notes that co-administered systemic medicines generally have no known clinically significant pharmacokinetic interactions. However, warnings mention using caution in patients with pre-existing conditions, such as uncontrolled hypertension or a history of cerebrovascular events.


Q: What should be done with unused Zacin 0.025% after the treatment is complete?

A: Unused or expired medication must be disposed of safely and in accordance with local requirements. It is important not to dispose of it in household trash or down the drain. Consultation with a pharmacist or local waste disposal service is recommended for guidance on proper disposal.


Q: Are there specific instructions for washing hands after applying Zacin 0.025%?

A: Regulatory guidance indicates that hands should be washed immediately with soap and water after application to prevent inadvertent contact with sensitive areas. If the treatment is applied to the hands themselves, they should be washed 30 minutes after application.


Q: Can Zacin 0.025% cause discoloration of the skin?

A: The primary local side effect listed in official documents is Erythema (redness). Persistent skin discoloration or hyperpigmentation is not typically listed among the commonly reported side effects.


Q: Does Zacin 0.025% contain preservatives or other inactive ingredients that might cause irritation?

A: The product contains the active ingredient capsaicin along with several inactive ingredients necessary for the cream formulation. While rare, these inactive components may occasionally cause localized allergic reactions or irritation in sensitive individuals.


Q: How does the risk profile of Zacin 0.025% compare between adults and children?

A: The product is not suitable for use in children and requires mandatory medical consultation for anyone under 18 years of age. This restriction is primarily due to insufficient data to fully establish the safety and appropriate use in the pediatric population.


Q: Are there any specific activities or foods to avoid while using Zacin 0.025%?

A: Activities that can intensify the sensory effect of the cream should be avoided. This includes applying heat sources (like heating pads) and taking hot showers, hot baths, or engaging in vigorous exercise within one hour of application. No specific foods are restricted.


Q: Is Zacin 0.025% safe for use by older adults?

A: Official labeling and regulatory documents state that the medicine is suitable for use by both adults and the elderly under standard labeled conditions. Individuals in this population may use the medicine as directed.


Q: What does 'systemic absorption' mean for a topical medicine like Zacin 0.025%?

A: Systemic absorption refers to the amount of medicine that passes through the skin and enters the general bloodstream to circulate throughout the body. For Zacin 0.025%, this absorption is officially noted to be minimal or low due to its topical application.


Q: Are there any known interactions between Zacin 0.025% and alcohol consumption?

A: Regulatory guidance and product documentation do not document known interactions between the medicine and moderate consumption of food, drinks, or alcohol.


Q: Can Zacin 0.025% be used under makeup or moisturizer?

A: Co-administration of other topical medicines, cosmetics, or skin care products on the exact same application area is generally advised against due to the potential for local pharmacodynamic effects. Usage guidelines often suggest applying Zacin 0.025% directly to clean, bare skin.


Q: Does Zacin 0.025% require special storage conditions?

A: Official storage requirements specify keeping the product at room temperature and protecting it from freezing. This means it does not require refrigeration or other 'special' temperature or humidity-controlled conditions.


Q: Is Zacin 0.025% known to cause allergic reactions?

A: Official information notes the potential for severe local hypersensitivity reactions (allergic reactions on the skin). In extremely rare cases, very serious systemic allergic reactions involving a rash, swelling, or trouble breathing are possible.

Advertisements

How should Zacin 0.025% be stored and disposed of?

Storage and Disposal Requirements for Zacin 0.025% Cream

Official regulatory information outlines specific conditions for storing and disposing of Zacin 0.025% (capsaicin) cream to maintain its stability and ensure safety.

Storage Conditions

Condition Requirement
Temperature Store at room temperature; keep from freezing.
Protection Keep away from excessive heat, moisture, and direct light.
Container Keep the medication in its original container, tightly closed.
Safety Store out of the sight and reach of children.

Disposal Rules

All unused or expired Zacin 0.025% cream and any related waste material must be disposed of in accordance with local requirements. Do not keep any outdated or no longer needed medication.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Zacin 0.025% found in:

A-Z Index: